Dr. Richard Schoske serves as Chief, Diagnostics, and Detection Division for the United States of America Defense Threat Reduction Agency (DTRA), Research and Development Directorate, Chemical Biological Technologies Department (RD-CB). In this capacity Dr. Schoske overseas and manages an $80 million Research and Development Portfolio. This portfolio includes projects in the areas of medical diagnostics, and chemical and biological agent detection.

His educational background is in Biochemistry, Chemistry and Clinical Laboratory Sciences. He has applied this knowledge in operational work experiences involving the development and deployment of novel medical diagnostic systems for the United States Air Force. Dr. Schoske has an extensive background in counter Chemical-Biological Consequence Management Planning. Prior to joining the DTRA, Dr. Schoske served in the United States Air Force for 21 years and is a retired Lieutenant Colonel.

During his time on active duty he served in numerous capacities including Chief, of a Medical Laboratory, Assistant Professor of Chemistry at the United States Air Force Academy, Principal Investigator in Diagnostic R&D, and Emergency Medical Planning. He was selected as a Senior Air Force Laboratory Fellow for Science and Technology and is an American Society of Clinical Pathologists Certified Medical Technologist. He earned a Master’s of Arts in Biochemistry from the University of Scranton, and a PhD in Chemistry from American University in Washington DC.